Introduction
Cytogenetic study of a patient with acute promyelocytic leukemia (APL) showed an unusual karyotype 46,xy,t(11;17) (q23;21) without apparent rearrangement of chromosome 15. Molecular studies showed rearrangements of the retinoic acid receptor alpha (RARa) gene but no rearrangement of the promyelocytic leukemia gene consistent with the cytogenetic data. Similar to t(15;17) APL, all-trans retinoic acid treatment in this patient produced an early leukocytosis which was followed by a myeloid maturation, but the patient died too early to achieve remission. Further molecular analysis of this patient showed a rearrangement between the RARa gene and a newly discovered zinc finger gene named PLZF (promyelocytic leukemia zinc finger). The fusion PLZF-RARa gene found in this case, was not found in DNA obtained from the bone marrow of normals, APL with t(15;1t) and in one patient with AML-M2 with a t(11;17). Fluorescence in situ hybridization using a PLZF-specific probe localized the PLZF gene to chromosomal band 1 1q23.1. Partial exon/intron structure of the PLZF gene flanking the break point on chromosome 11 was also established and the breakpoint within the RARa gene was mapped -2 kb downstream of the exon encoding the 5' untranslated region and the unique A2 domain of the RARa 2 isoform. (J. Clin. Invest. 1993 .91:2260-2267.) Key words: novel gene rearrangements * retinoic acid receptor * leukemia Acute promyelocytic leukemia (APL)' is characterized by the chromosomal translocation t( 15; 17) (q22;q21) that is present in almost all patients (1, 2) . Recently, molecular studies showed that the t(15;17) results in a chimeric gene (PMLRARa) with fusion between promyelocytic leukemia (PML) and retinoic acid receptor alpha (RARa) genes normally localized on bands 15q22 and 17q2 1, respectively (3, 4) . RARa is a member of the nuclear receptor superfamily gene, whereas PML may be a transcription factor belonging to a new family of DNA binding proteins (5-7). The chimeric PML-RARa gene is thought to play an important (but as yet undefined) role in differentiation and/or proliferation of APL cells. Variant translocations have been reported in APL. They are in most instances three way translocations involving chromosomes 17, 15, and a third chromosome (8) . Here we present clinical and cytogenetic data on a Chinese patient with APL and a variant translocation t( 1; 17 )(q23;2 1) between a newly discovered gene (9) , designated as PLZF (promyelocytic leukemia zinc finger), and the RARa locus. The PLZF gene is normally situated on a band 1 1q23.1 and is fused to RARa as a result of the above reciprocal translocation to form two new chimeric genes PLZF-RARa and RARa-PLZF. Additionally, we show that both PLZF(A)-RARa and PLZF(B)-RARa mRNAs were expressed in the bone marrow cells isolated from this patient. and free from repetitive sequences was isolated for in situ hybridization and Southern analysis. Subsequently, a 2. 1-kb BgIII-EcoRI fragment situated just 3' to the MB probe was generated to perform the chromosome walking.
In situ hybridization. Fluorescence in situ hybridization to high resolution R-banded metaphase chromosomes was performed with the biotinylated probe MB, according to ( 14) . Chromosomes were examined with a Leitz fluorescence microscope as previously described ( 14) .
Reverse transcription PCR (RT-PCR) analysis. RNAs were extracted with the guanidium thiocyanate CsCl gradient method. The general conditions of RT-PCR were according to the previously described procedure ( 15) . PLZF specific primers were designed according to the PLZF cDNA sequence (9) whereas primers homologous to PML and RARa were according to the previously published sequences (6) (see Fig. 6 A) for the positions ofeach oligos). In both PML-RARa and PLZF-RARa analyses, the same set of RARa derived oligonucleotides were used as retrotranscription primer (oligo g: 5'GTTCGTAGT-GTATTTGCCCAGCTGGCAGAG 3') and the 3' PCR primer (oligo f: 5' GGCTTGTAGATGCGGGGTAG 3'). The 5' primer used in PML-RARa RT-PCR was derived from PML exon 3 (5' ATGGCT-TCGACGAGTTCAAG 3') allowing the detection of both long (L) and short (S) PML-RARa isoforms (15 
Results
Clinical data. The patient was a 67-yr-old man complaining about weakness and anorexia for 1 mo, as well as coughing and gingival bleeding for a few days. Physical examination noted pallor, signs of bronchitis, purpura of the tongue without other obvious bleeding signs, cervical lymphadenopathy, and absence of hepatosplenomegaly. The renal and hepatic function tests were normal. Disseminated intravascular coagulation was not diagnosed, but occult blood in the stool was detected. The peripheral white blood cell count was 4.1 X 109/liter. Bone marrow was hypercellular with 69% APL-like promyelocytes, but without Auer rods. The myeloperoxidase reaction was strongly positive.
The patient was classified as APL and was given all-trans retinoic acid (ATRA) at a dose of 60 mg/d. On day 8, the white blood cell count increased to 61 X 109/liter with 72% promy- (Fig. 2) . The two remaining metaphases showed the t ( 1;1,7) and chromosome random losses.
Molecular evidence demonstrating thefusions between the RARa and PLZF genes. Southern analysis of DNA obtained from the patient with t( 1 1; 17 ) APL revealed no rearrangement of the PML gene (data not shown) and using a PLZF genomic DNA probe (MB) (see Fig. 3 A, IV) revealed rearranged bands following EcoRI and HindIII digestion (Fig. 3 B) . No rearrangements or PLZF were detected in bone marrow DNAs in three normals, 10 APL patients with t( 15;17), and one AML-M2 with a t( 11;17) (data not shown).
The RARa gene was also rearranged in this case and the rearranged bands in EcoRI and HindIII revealed by both probes had the same size. According to our previously established RARa restriction map (Fig. 3 A, I (Fig. 3 A, IV) . We Both PLZF (A)-RARa and PLZF (B)-RARa chimeric transcripts are expressed in patient with t( 1;1 7) positive APL. Recently, we have described the existence of two PLZF isoforms (A) and (B), differing by a proline-rich 369-bp exon that probably resulted from an alternative splicing mechanism (9) . As the proline-rich domain has been implicated in transcription regulation, it was important to see if both PLZF isoforms could be transcribed in the PLZF-RARa fusion gene mRNA. Therefore, we performed RT-PCR using primers homologous to this exon and to the RARa B region. A specific band was obtained in the t ( 1 1; 17) sample but not in two t( 15; 17) samples (Fig. 6 B) . Furthermore, when the 5' primers were replaced by those just upstream ofthis exon, two amplified bands were observed (Fig. 6 B) . These results were confirmed by sequence analysis and demonstrated that two PLZF-RARa isoforms existed in the t( 11;1;7) patient, which differed from each other by the presence or absence of one PLZF exon. As shown in previous work, two isoforms of RARa-PLZF transcripts were also present in this case by the use of RARa1 or RARa2 promoters. This is consistent with the genomic structure of the reciprocal fusion gene RARa-PLZF (Fig. 3 A,   III A variant t( 11; 17) positive APL was previously reported (18) but not studied for molecular rearrangements. In the present case, the t( 1 1; 17) was associated with rearrangement ofthe RARa gene while the PML gene was structurally intact. The chromosome 11 gene (PLZF) involved in rearrangement with RARa in this unique case ofAPL has recently been cloned (9) . This gene has some homology with the zinc finger gene MZF-1 ( 19) and is also retinoic acid responsive and preferentially expressed in myeloid cells ( 19) . Because of t ( 1 1; 17) , the PLZF gene is disrupted in its zinc finger containing region, with fusion of two zinc fingers to the RARa B region in the PLZFRARa fusion gene, while seven zinc fingers joined the RARa region in the reciprocal RARa-PLZF chimeric gene. It is noteworthy that the RARa gene was disrupted in its third intron as commonly found in the standard t ( 15, 17) . The association of both PML-RARa and PLZF-RARa fusions with the APL phenotype argues for a key role for RARa in the hybrid genes. In support of this is the observation that two cases of myelodysplastic syndrome transformed to APL with trisomy 11 without RARa rearrangements, failed to respond to ATRA (20) . However, since the role ofPML and PLZF in leukemic cell proliferation and differentiation remains largely unknown, it is also possible that PML and PLZF have an equivalent function when rearranged with the RARa gene.
Chromosomal band 1 1q23 is rearranged in several varieties of hematopoietic malignancies (17) . Breakpoints of chromosome 11 in acute leukemias with t(4;11 ), t(6;11 ), t(9;l 1 ) and t( 11; 19) have been localized within 300 kb downstream ofthe CD3D gene (21) (22) (23) (24) . The breakpoint was found more distal in a leukemia with t( 11; 19) than in leukemias with one of the other three translocations (25) , suggesting that there is a heterogeneity in the localization of the breakpoints within the band 1 lq23, as already shown for the t( 11;14)(q23p;q32) translocation oflymphoid malignancies (26, 27) . The localization ofthe PLZF gene on 1 1q23. 1, which is centrometric to the other breakpoint localizations ofmost ofthe recurrent translocations of hematopoietic malignancies, also argues in favor of the breakpoint heterogeneity of malignancies with 1 1q23 rearrangements. Interestingly, the molecular study of another translocation t( 11; 17) detected in a patient with acute myeloblastic leukemia M2, and thus clinically and cytologically different from APL, did not show rearrangements of the RARa nor PLZF genes. In our most recent studies, we have identified a second case of t( 11;1;7) APL (in collaboration with Wilson Miller) which expressed the PLZF-RARa fusion gene. This is concordant with the specificity of the gene rearrangements in APL. The PLZF gene is a putative transcription factor that appears to be associated with myeloid differentiation (9) and may be deranged in other myeloid malignancies. The identification of PLZF justifies that molecular studies of other APL variant translocations should be systematically performed to determine if genes other than PML (or RARa) may be involved in these APLs.
